You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cyclophosphamide

Showing 26 - 50 of 5,137
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Solid Tumor Trial in New Brunswick

Active, not recruiting
  • Ann Arbor Stage III Non-Hodgkin Lymphoma
  • +2 more
  • Cyclophosphamide
  • +4 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 28, 2023

Tofatib Treatment for IgG4-related Disease

Recruiting
  • IgG4-related Disease
  • Shanghai, Shanghai, China
    Shanghai Changhai Hospital
Nov 15, 2022

Idiopathic Refractory Scleritis Trial (Infliximab, Cyclophosphamide)

Withdrawn
  • Idiopathic Refractory Scleritis
  • (no location specified)
Jul 18, 2022

TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • (no location specified)
May 8, 2023

Pleural Mesothelioma Trial in Toronto (Cyclophosphamide, Fludarabine, Autologous tumor infiltrating lymphocytes (TILs))

Completed
  • Pleural Mesothelioma
  • Cyclophosphamide
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jan 8, 2023

Idiopathic Membranous Nephropathy Trial (Rituximab, Cyclophosphamide)

Not yet recruiting
  • Idiopathic Membranous Nephropathy
  • (no location specified)
Aug 22, 2022

Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul

Active, not recruiting
  • Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
  • Cyclophosphamide
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023

Hematological Malignancies Trial (Allogeneic T cell progenitors, cultured ex-vivo)

Not yet recruiting
  • Hematological Malignancies
  • Allogeneic T cell progenitors, cultured ex-vivo
  • (no location specified)
Mar 2, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in

Not yet recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Biospecimen Collection
  • +8 more
  • Kansas City, Kansas
    University of Kansas Cancer Center
Nov 27, 2023

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in Toulouse (Doxorubicin, Cyclophosphamide)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Toulouse, France
    Institut Claudius Reagaud-IUCT Oncopôle
Oct 6, 2022

Multiple Myeloma, Monoclonal Gammopathy of Renal Significance Trial in United States (Cyclophosphamide, Bortezomib,

Recruiting
  • Multiple Myeloma
  • Monoclonal Gammopathy of Renal Significance
  • Cyclophosphamide
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Oct 16, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia Trial in United States (drug, procedure, other, radiation)

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +10 more
  • Jacksonville, Florida
  • +5 more
Aug 14, 2023

Breast Cancer, Chemo Effect Trial (Epirubicin, Cyclophosphamide, Xihuang Pill, Docetaxel, Epirubicin, Cyclophosphamide,

Not yet recruiting
  • Breast Cancer
  • Chemotherapy Effect
  • Epirubicin, Cyclophosphamide, Xihuang Pill, Docetaxel
  • Epirubicin, Cyclophosphamide, Docetaxel
  • (no location specified)
Jun 21, 2023

Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial run

Recruiting
  • Severe Aplastic Anemia (SAA)
  • +2 more
  • Cyclophosphamide
  • Peripheral Blood Stem Cells
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 28, 2023

Lipodystrophy Acquired, Type1diabetes Trial in Shanghai (Cyclophosphamide)

Recruiting
  • Lipodystrophy Acquired
  • Type1diabetes
  • Cyclophosphamide
  • Shanghai, Shanghai, China
    Children's Hospital of Fudan University
Jul 20, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Cyclophosphamide
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Breast Cancer Trial in Chicago (Cyclophosphamide, Methotrexate, Capecitabine)

Recruiting
  • Breast Cancer
  • Cyclophosphamide
  • +2 more
  • Chicago, Illinois
    University of Illinois
Oct 18, 2023

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,

Recruiting
  • Primary Immune Deficiency Disorder
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins University
Oct 20, 2022

Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention)

Active, not recruiting
  • Graft-versus-host Disease
  • Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention
  • New York, New York
    NYU Langone Health
Aug 5, 2022

Transplant-Related Hematologic Malignancy Trial in Atlanta (Sargramostim, Control Arm)

Recruiting
  • Transplant-Related Hematologic Malignancy
  • Atlanta, Georgia
    Northside Hospital
Oct 19, 2022

Ovarian Carcinoma Trial (PEP-DC1, OC-DC, PEP-DC2)

Not yet recruiting
  • Ovarian Carcinoma
  • PEP-DC1
  • +3 more
  • (no location specified)
Jan 26, 2023

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, MDS Trial in Tucson (Bendamustine, Cyclophosphamide)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +12 more
  • Tucson, Arizona
    The University of Arizona Cancer Center
Dec 13, 2022

Lymphoblastic Leukemia in Children Trial (induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal

Not yet recruiting
  • Lymphoblastic Leukemia in Children
  • induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal Methotrexate
  • +7 more
  • (no location specified)
Oct 24, 2023

Refractory Solid Tumor, Hepatocellular Carcinoma, Malignant Solid Tumor Trial in Memphis (Atezolizumab, Sorafenib, Bevacizumab)

Recruiting
  • Refractory Solid Tumor
  • +4 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Aug 4, 2022